The national PANORAMIC trial is testing new antiviral treatments that help those suffering with Covid-19 at home and in the community get better quicker and without needing to be treated in hospital.All treatments in the PANORAMIC trial have been approved by the UK Medicines and Health Care Products Regulatory Agency (MHRA) for use in the study.
You can join the study directly by filling out the screening form:
STEP HFpEF (Semaglutide Treatment Effect in People with Obesity, Heart Failure with Preserved Ejection Fraction)
This study will investigate how well a new drug called semaglutide works at helping people lose weight and reduce symptoms of heart failure.
Participation in the study will last for 59 weeks.
It is being carried out in Greater Manchester by a team cased at the Manchester Heart Centre, part of Manchester University NHS Foundation Trust.
This study is testing a vaccine to be used as a booster to prevent coronavirus infection (COVID-19).
It is sponsored by Gritstone bio, Inc and is being carried out by a team of researchers at Manchester University NHS Foundation Trust.
This study is testing how effective a new vaccine is in preventing respiratory infections caused by the respiratory syncytial virus (RSV).
Respiratory syncytial virus (RSV) is a common seasonal virus that infects the airways of the lungs. Some people, especially older adults or those living with some long-term conditions, can experience serious complications, including inflammation of the lungs of pneumonia.
This international study is being carried out in Greater Manchester by a team of researchers at Manchester University NHS Foundation Trust.
A study looking at whether a new medication can treat painful neuropathy (nerve pain) in people who have diabetes.